Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2019 Sep 22

PMID 31540066

Citations 7

Authors

Silvia Pescina

Leticia Grolli Lucca

Paolo Govoni

Cristina Padula

Elena Del Favero

Laura Cantu

Patrizia Santi

Sara Nicoli

Affiliations

Soon will be listed here.

Abstract

This paper addresses the problem of ocular delivery of lipophilic drugs. The aim of the paper is the evaluation of polymeric micelles, prepared using TPGS (d-α-Tocopheryl polyethylene glycol 1000 succinate), a water-soluble derivative of Vitamin E and/or poloxamer 407, as a vehicle for the ocular delivery of dexamethasone, cyclosporine, and econazole nitrate. The research steps were: (1) characterize polymeric micelles by dynamic light scattering (DLS) and X-ray scattering; (2) evaluate the solubility increase of the three drugs; (3) measure the in vitro transport and conjunctiva retention, in comparison to conventional vehicles; (4) investigate the mechanisms of enhancement, by studying drug release from the micelles and transconjunctival permeation of TPGS; and (5) study the effect of micelles application on the histology of conjunctiva. The data obtained demonstrate the application potential of polymeric micelles in ocular delivery, due to their ability to increase the solubility of lipophilic drugs and enhance transport in and across the conjunctival epithelium. The best-performing formulation was the one made of TPGS alone (micelles size ≈ 12 nm), probably because of the higher mobility of these micelles, an enhanced interaction with the conjunctival epithelium, and, possibly, the penetration of intact micelles.

Citing Articles

Polymeric Mixed Micelle-Loaded Hydrogel for the Ocular Delivery of Fexofenadine for Treating Allergic Conjunctivitis.

El-Shahed S, Hassan D, El-Nabarawi M, El-Setouhy D, Abdellatif M Polymers (Basel). 2024; 16(16).

PMID: 39204460 PMC: 11359231. DOI: 10.3390/polym16162240.

Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms.

Gugleva V, Andonova V Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986574 PMC: 10058782. DOI: 10.3390/ph16030474.

Nanostructured Lipid Carriers for Enhanced Transscleral Delivery of Dexamethasone Acetate: Development, Ex Vivo Characterization and Multiphoton Microscopy Studies.

Gonzalez-Fernandez F, Delledonne A, Nicoli S, Gasco P, Padula C, Santi P Pharmaceutics. 2023; 15(2).

PMID: 36839729 PMC: 9961953. DOI: 10.3390/pharmaceutics15020407.

An Alternative Device for the Topical Treatment of Oral Cancer: Development and Ex-Vivo Evaluation of Imiquimod-Loaded Polysaccharides Formulations.

Remiro P, Nagahara M, Ghezzi M, Filippini A, Demurtas A, Pescina S Pharmaceutics. 2022; 14(12).

PMID: 36559066 PMC: 9785792. DOI: 10.3390/pharmaceutics14122573.

Improvement of Imiquimod Solubilization and Skin Retention via TPGS Micelles: Exploiting the Co-Solubilizing Effect of Oleic Acid.

Ghezzi M, Pescina S, Delledonne A, Ferraboschi I, Sissa C, Terenziani F Pharmaceutics. 2021; 13(9).

PMID: 34575553 PMC: 8469695. DOI: 10.3390/pharmaceutics13091476.

References

Urtti A, Salminen L . Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 1993; 37(6):435-56. DOI: 10.1016/0039-6257(93)90141-s. View

Sasaki H, Yamamura K, Tei C, Nishida K, Nakamura J . Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug. J Drug Target. 1995; 3(2):129-35. DOI: 10.3109/10611869509059212. View

Hosoya K, Lee V, Kim K . Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation. Eur J Pharm Biopharm. 2005; 60(2):227-40. DOI: 10.1016/j.ejpb.2004.12.007. View

Wang W, Sasaki H, Chien D, Lee V . Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr Eye Res. 1991; 10(6):571-9. DOI: 10.3109/02713689109001766. View

Hamalainen K, Kananen K, Auriola S, Kontturi K, Urtti A . Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci. 1997; 38(3):627-34. View

Yang J, Kim K, Lee V . Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers. Pharm Res. 2000; 17(5):533-8. DOI: 10.1023/a:1007508714259. View

Vellonen K, Hellinen L, Mannermaa E, Ruponen M, Urtti A, Kidron H . Expression, activity and pharmacokinetic impact of ocular transporters. Adv Drug Deliv Rev. 2017; 126:3-22. DOI: 10.1016/j.addr.2017.12.009. View

Fathalla Z, Vangala A, Longman M, Khaled K, Hussein A, El-Garhy O . Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies. Eur J Pharm Biopharm. 2017; 114:119-134. DOI: 10.1016/j.ejpb.2017.01.008. View

Elmowafy E, Gad H, Biondo F, Casettari L, Soliman M . Exploring optimized methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) crystalline cored micelles in anti-glaucoma pharmacotherapy. Int J Pharm. 2019; 566:573-584. DOI: 10.1016/j.ijpharm.2019.06.011. View

10.

Di Tommaso C, Bourges J, Valamanesh F, Trubitsyn G, Torriglia A, Jeanny J . Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies. Eur J Pharm Biopharm. 2012; 81(2):257-64. DOI: 10.1016/j.ejpb.2012.02.014. View

11.

Sasaki H, Yamamura K, Mukai T, Nishida K, Nakamura J, Nakashima M . Modification of ocular permeability of peptide drugs by absorption promoters. Biol Pharm Bull. 2001; 23(12):1524-7. DOI: 10.1248/bpb.23.1524. View

12.

Ramsay E, Ruponen M, Picardat T, Tengvall U, Tuomainen M, Auriola S . Impact of Chemical Structure on Conjunctival Drug Permeability: Adopting Porcine Conjunctiva and Cassette Dosing for Construction of In Silico Model. J Pharm Sci. 2017; 106(9):2463-2471. DOI: 10.1016/j.xphs.2017.04.061. View

13.

Baranowski P, Karolewicz B, Gajda M, Pluta J . Ophthalmic drug dosage forms: characterisation and research methods. ScientificWorldJournal. 2014; 2014:861904. PMC: 3977496. DOI: 10.1155/2014/861904. View

14.

Juretic M, Cetina-cizmek B, Filipovic-Grcic J, Hafner A, Lovric J, Pepic I . Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models. Eur J Pharm Sci. 2018; 120:133-141. DOI: 10.1016/j.ejps.2018.04.032. View

15.

Caruso C, Ostacolo C, Epstein R, Barbaro G, Troisi S, Capobianco D . Transepithelial Corneal Cross-Linking With Vitamin E-Enhanced Riboflavin Solution and Abbreviated, Low-Dose UV-A: 24-Month Clinical Outcomes. Cornea. 2015; 35(2):145-50. PMC: 4705913. DOI: 10.1097/ICO.0000000000000699. View

16.

Yu Y, Chen D, Li Y, Yang W, Tu J, Shen Y . Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies. Drug Deliv. 2018; 25(1):888-899. PMC: 6058700. DOI: 10.1080/10717544.2018.1458923. View

17.

Dumee L, Lemoine J, Ancel A, Hameed N, He L, Kong L . Control of Partial Coalescence of Self-Assembled Metal Nano-Particles across Lyotropic Liquid Crystals Templates towards Long Range Meso-Porous Metal Frameworks Design. Nanomaterials (Basel). 2017; 5(4):1766-1781. PMC: 5304782. DOI: 10.3390/nano5041766. View

18.

Saha P, Yang J, Lee V . Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells. Invest Ophthalmol Vis Sci. 1998; 39(7):1221-6. View

19.

Lakhani P, Patil A, Majumdar S . Challenges in the Polyene- and Azole-Based Pharmacotherapy of Ocular Fungal Infections. J Ocul Pharmacol Ther. 2018; 35(1):6-22. PMC: 6354613. DOI: 10.1089/jop.2018.0089. View

20.

Hou Y, Zhang F, Lan J, Sun F, Li J, Li M . Ultra-small micelles based on polyoxyl 15 hydroxystearate for ocular delivery of myricetin: optimization, in vitro, and in vivo evaluation. Drug Deliv. 2019; 26(1):158-167. PMC: 6407586. DOI: 10.1080/10717544.2019.1568624. View